Circulation, Vol 69, 223-232, Copyright © 1984 by American Heart Association
TS Ivert, WE Dismukes, CG Cobbs, EH Blackstone, JW Kirklin and LA Bergdahl
Fifty-three (3.6%; actuarially 4.1% at 48 months) of 1465 consecutive
in-hospital survivors of valve replacement from 1975 to July 1979 (aortic,
mitral, or aortic and mitral, only one untraced) developed prosthetic valve
endocarditis (PVE). Incremental risk factors for developing PVE were native
valve endocarditis (p less than .0001), black race (p = .0001), mechanical
prosthesis (vs bioprosthesis) (p = .005), male sex (p = .04), and longer
cardiopulmonary bypass time (p = .09). In general, the hazard function for
developing PVE was greatest at 3 weeks after valve replacement. Patients
with native valve endocarditis had a tendency to develop PVE early after
valve replacement, as did patients in whom mechanical prostheses were used.
PVE associated with Staphylococcus epidermidis tended to appear within 6
months of valve replacement, whereas streptococcal PVE tended to appear
later after valve replacement. PVE took an atypical form in some patients,
but patients with possible PVE (n = 6) had the same findings as those with
certain PVE (n = 47). In 11 patients bacteriologic confirmation of PVE was
not obtained. The typical prosthetic and periprosthetic characteristics of
PVE were present in 30 of the 40 cases in which observations were possible.
PVE is a serious condition; 34 (64%) of our 53 patients died. Most deaths
occurred within 3 months of the first evidence of PVE. Recovery of some
patients is possible with appropriate medical and surgical treatment, but
more intense preventive measures are indicated.
ARTICLES
Prosthetic valve endocarditis
This article has been cited by other articles:
 |
|
 |
|
  S. C. Stamou, G. Petterson, and A. M. Gillinov Surgical Treatment of Mitral Valve Endocarditis Card. Surg. Adult, January 1, 2008; 3(2008): 1069 - 1078. [Full Text]
|
|
|
|
 |
|
 M. C. Farinas, A. Perez-Vazquez, C. Farinas-Alvarez, J. D. Garcia-Palomo, J. M. Bernal, J. M. Revuelta, and J. Gonzalez-Macias Risk Factors of Prosthetic Valve Endocarditis: A Case-Control Study Ann. Thorac. Surg., April 1, 2006; 81(4): 1284 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.J. Todd, S.J. Leslie, M. MacDougall, and M.A. Denvir Clinical features remain important for the diagnosis of infective endocarditis in the modern era QJM, January 1, 2006; 99(1): 23 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Mahesh, G. Angelini, M. Caputo, X. Y. Jin, and A. Bryan Prosthetic Valve Endocarditis Ann. Thorac. Surg., September 1, 2005; 80(3): 1151 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nottin, N. Al-Attar, R. Ramadan, A. Azmoun, A. Therasse, C. Kortas, M. Ly, A. Bouchachi, and M.-L. Bourachot-Montanteme Aortic Valve Translocation for Severe Prosthetic Valve Endocarditis: Early Results and Long-Term Follow-Up Ann. Thorac. Surg., May 1, 2005; 79(5): 1486 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shapira, O. Merin, E. Rosenmann, I. Dzigivker, D. Bitran, A. M. Yinnon, and S. Silberman Latent Infective Endocarditis: Epidemiology and Clinical Characteristics of Patients With Unsuspected Endocarditis Detected After Elective Valve Replacement Ann. Thorac. Surg., November 1, 2004; 78(5): 1623 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.J. van Gorp, E.W. Steyerberg, and Y. van der Graaf Decision Guidelines for Prophylactic Replacement of Bjork-Shiley Convexo-Concave Heart Valves: Impact on Clinical Practice Circulation, May 4, 2004; 109(17): 2092 - 2096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Kojic and R. O. Darouiche Candida Infections of Medical Devices Clin. Microbiol. Rev., April 1, 2004; 17(2): 255 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Ionescu, A G Fraser, and E G Butchart Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography Heart, November 1, 2003; 89(11): 1316 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Grijalva, R Horvath, M Dendis, J Erny, and J Benedik Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients Heart, March 1, 2003; 89(3): 263 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E F Akowuah, W Davies, S Oliver, J Stephens, I Riaz, P Zadik, and G Cooper Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment Heart, March 1, 2003; 89(3): 269 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Desai and G. T. Christakis Stented Mechanical/Bioprosthetic Aortic Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856. [Full Text]
|
|
|
|
|
|
J. F. Sabik, B. W. Lytle, E. H. Blackstone, A. G.M. Marullo, G. B. Pettersson, and D. M. Cosgrove Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis Ann. Thorac. Surg., September 1, 2002; 74(3): 650 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Huth, A. Friedl, A. Rost, and for the GELIA Study Investigator Group Intensity of oral anticoagulation after implantation of St. Jude Medical aortic prosthesis: analysis of the GELIA Database (GELIA 4) Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q33 - Q38. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Mylonakis and S. B. Calderwood Infective Endocarditis in Adults N. Engl. J. Med., November 1, 2001; 345(18): 1318 - 1330. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Seipelt, J. F. Vazquez-Jimenez, I. M. Seipelt, A. Franke, K. Chalabi, F. A. Schoendube, and B. J. Messmer The St. Jude ""Silzone"" valve: midterm results in treatment of active endocarditis Ann. Thorac. Surg., September 1, 2001; 72(3): 758 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Seto, D. Kwiat, D. A. Taira, P. S. Douglas, and W. J. Manning Physicians' Recommendations to Patients for Use of Antibiotic Prophylaxis to Prevent Endocarditis JAMA, July 5, 2000; 284(1): 68 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Safi, T. Kwan, E. Afflu, A. Al Kamme, and L. Salciccioli Paravalvular Regurgitation: A Rare Complication Following Valve Replacement Surgery Angiology, June 1, 2000; 51(6): 479 - 487. [Abstract] [PDF]
|
|
|
|
|
|
J C Castillo, M P Anguita, A Ramírez, J R Siles, F Torres, D Mesa, M Franco, I Muñoz, M Concha, and F Vallés Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study Heart, May 1, 2000; 83(5): 525 - 530. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Perez-Vazquez, M. C. Farinas, J. D. Garcia-Palomo, J. M. Bernal, J. M. Revuelta, and J. Gonzalez-Macias Evaluation of the Duke Criteria in 93 Episodes of Prosthetic Valve Endocarditis: Could Sensitivity Be Improved? Arch Intern Med, April 24, 2000; 160(8): 1185 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. N. Campbell, W. Tsai, and L. A. Mispireta Evaluation of the practice of routine culturing of native valves during valve replacement surgery Ann. Thorac. Surg., February 1, 2000; 69(2): 548 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tornos, B. Almirante, S. Mirabet, G. Permanyer, A. Pahissa, and J. Soler-Soler Infective Endocarditis Due to Staphylococcus aureus: Deleterious Effect of Anticoagulant Therapy Arch Intern Med, March 8, 1999; 159(5): 473 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Choussat, D. Thomas, R. Isnard, P.-L. Michel, B. Iung, G. Hanania, P. Mathieu, M. David, T. du Roy de Chaumaray, G. De Gevigney, et al. Perivalvular abscesses associated with endocarditis: Clinical features and prognostic factors of overall survival in a series of 233 cases Eur. Heart J., February 1, 1999; 20(3): 232 - 241. [Abstract] [PDF]
|
|
|
|
|
|
K. M. Dossche, J. J. Defauw, S. M. Ernst, T. W. Craenen, B. M. De Jongh, and A. B. de la Riviere Allograft Aortic Root Replacement in Prosthetic Aortic Valve Endocarditis: A Review of 32 Patients Ann. Thorac. Surg., June 1, 1997; 63(6): 1644 - 1649. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. G. French, K. Wilson, M. Wong, S. Smith, and M. F. O'Brien RIFAMPICIN ANTIBIOTIC IMPREGNATION OF THE ST. JUDE MEDICAL MECHANICAL VALVE SEWING RING: A WEAPON AGAINST ENDOCARDITIS J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 248 - 252. [Abstract] [Full Text]
|
|
|
|
|
|
A. K. Agnihotri, D. C. McGiffin, A. J. Galbraith, and M. F. O'Brien THE PREVALENCE OF INFECTIVE ENDOCARDITIS AFTER AORTIC VALVE REPLACEMENT J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1708 - 1724. [Abstract] [Full Text]
|
|
|
|
|
|
H. Shiro, G. Meluleni, A. Groll, E. Muller, T. D. Tosteson, D. A. Goldmann, and G. B. Pier The Pathogenic Role of Staphylococcus epidermidis Capsular Polysaccharide/Adhesin in a Low-Inoculum Rabbit Model of Prosthetic Valve Endocarditis Circulation, November 1, 1995; 92(9): 2715 - 2722. [Abstract] [Full Text]
|
|
|
|
|
|
D. D. Muehrcke, B. W. Lytle, and D. M. Cosgrove III Surgical and Long-Term Antifungal Therapy for Fungal Prosthetic Valve Endocarditis Ann. Thorac. Surg., September 1, 1995; 60(3): 538 - 543. [Abstract] [Full Text]
|
|
|
|
|
|
W. W. O'Neill, J. G. Chandler, R. E. Gordon, D. M. Bakalyar, A. H. Abolfathi, M. D. Castellani, J. L. Hirsch, D. W. Wieting, J. S. Bassett, K. C. Beatty, et al. Radiographic Detection of Strut Separations in Bjork-Shiley Convexo-Concave Mitral Valves N. Engl. J. Med., August 17, 1995; 333(7): 414 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Durack Prevention of Infective Endocarditis N. Engl. J. Med., January 5, 1995; 332(1): 38 - 44. [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Gold and J. C. Rios Iatrogenic Cardiovascular Disease Secondary to Diagnostic and Therapeutic Procedures J Intensive Care Med, January 1, 1987; 2(1): 49 - 60. [Abstract] [PDF]
|
|